NEW YORK - The American College of Obstetricians and Gynecologists has issued a new set of guidelines, recommending that prenatal aneuploidy screening be offered to all pregnant people regardless of their age or other risk factors.
Although the document endorses multiple methods — both the traditional serum protein screen with or without nuchal translucency ultrasound and the newer generation of cell-free DNA-based non-invasive tests — ACOG specifically stated in the new guidelines that cfDNA assays, known as non-invasive prenatal tests, offer superior sensitivity and specificity.